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ABSTRACT In Saccharomyces cerevisiae, at least 17 DNA
replication genes are coordinately expressed at the G1/S
boundary during the cell cycle. All of these genes have the DNA
sequence element ACGCGT in their 5' upstream regulatory
regions. This sequence has been shown to be essential for
periodic expression of the POLI, CDC9, and TMPI genes. The
cyclin (CLNI and CLN2) and HO genes are another subset of
genes that are expressed with the same timing as the DNA
replication genes. Their periodic expression requires the par-
ticipation of two well-characterized transcriptional activators:
the SWI4 and SWI6 gene products. In this study, we present
evidence that SWI6 contributes to the regulation of DNA
replication genes as well. Surprisingly, a preferential require-
ment for SWI6 over SWI4 is observed in our studies of
ACGCGT-dependent reporter gene expression in vivo. This
selectivity has not been observed for the other G1/S genes.
Correlating with the in vivo results, protein-DNA complexes
formed in vitro on multimeric ACGCGT elements are either
abolished or reduced in swi6A deletion mutants.
In Saccharomyces cerevisiae, at least 17 DNA replication
genes are induced coordinately at the G1/S boundary of the
cell cycle. All of these genes have one copy or more of the
consensus sequence ACGCGT in their upstream regulatory
sequences (refs. 1 and 2; reviewed in ref. 3). That this
conserved sequence is indeed required for periodic gene
induction has been directly demonstrated for the TMPI (4),
POLI (5), and CDC9 (6) genes. Multimeric copies of the
conserved hexamer can function as an upstream activation
sequence as well as confer periodic activation on the heter-
ologous lacZ gene (6). Since this sequence conforms to the
recognition site for the Mlu I restriction endonuclease, it has
been named the Mlu I cell cycle box (MCB).
In addition to the DNA replication genes, a number of
other genes are known whose transcription is dependent on
passage through Start. The cell cycle-regulated transcription
ofthis second group ofgenes is known to be controlled by two
transcription factors, encoded by SWI4 and SWI6. The genes
controlled by SWI4 and SWI6 include CLNJ and CLN2,
which encode two known G1 cyclins, HCS26, which encodes
a putative G1 cyclin, and HO, whose product initiates cell
type switching (7-9). SWI4 and SWI6 are known to act
through a repeated sequence element, the SWI4,6-dependent
cell cycle box (SCB), found 2-10 times in the upstream
regulatory sequences of target genes. The consensus se-
quence for the SCB (CACGGAAAA), as originally defined
through studies of the HO upstream regulatory region (10), is
clearly different from the MCB sequence (ACGCGT). How-
ever, a consideration of the SCB elements of other genes as
well as mutational analysis of the SCB has allowed deduction
ofa revised consensus sequence that reveals a core similarity
between the two elements: aCGCGt (MCB) compared with
(C)(G)CGa (matches between the two sequences are capital-
ized whereas parentheses indicate that the residue is one
possible choice for that position) (11).
Given the core resemblance between the SCB and MCB
sequences and the similar timing of expression of genes
controlled by the two elements, we have investigated the
potential role ofSWI4 and SWI6 in the regulation ofthe DNA
replication genes. We have tested the ability of the MCB
sequence to function as an upstream activation sequence
(UAS) in swi4A and swi6A deletion mutants. We find that
MCB-dependent UAS activity is totally abolished in swi6A
strains but is affected much less (2- to 8-fold) by deletion of
swi4. The behavior of the MCB sequence in swi4A and swi6A
mutants differs from that of the SCB element, which exhibits
an absolute requirement for both SWI4 and SWI6 in order to
function to activate transcription. Using gel mobility-shift
assays, we have observed several protein complexes from
crude yeast extracts that are specific for the MCB sequence.
Formation of one complex is abolished and formation of a
second complex is reduced in an swi6A deletion mutant.
Taken together, the in vitro and in vivo data support a role for
the Swi6 protein in regulating periodic transcription of the
DNA replication genes.
MATERIALS AND METHODS
Plasmid Constructs and (3-Galactosidase Assays. Plasmids
containing the MCB consensus sequence were constructed
by insertion of a synthetic MCB cassette. Two complemen-
tary oligomers with Xho I sticky ends, 5'-TCGAGCT-
TGACGCGTTAAG-3' and 5'-TCGACTTAACGCGT-
CAAGC-3', were annealed and cloned into the Xho I site
upstream of the CYCI TATA box in the vector pASS (7).
pA&SS contains on a yeast vector the CYCI promoter fused to
lacZ but lacking UAS elements. Plasmid pBA486 carries
three tandem copies of this cassette upstream of the CYCJ
promoter; plasmid pBA487 carries four copies of the cas-
sette. A second, smaller cassette carrying the MCB sequence
was also inserted into the UAS assay system. This cassette
was formed of the self-complementary oligonucleotide 5'-
TCGAGACGCGTC-3' and is present in two copies upstream
of the CYCI promoter in pBA487.
Yeast transformations were performed by a modification of
the lithium acetate protocol of Ito et al. (12). For 8-galacto-
sidase assays, individual yeast transformants were grown to
saturation in synthetic medium lacking uracil (SD-ura) to
select for the tester plasmids. Cultures were diluted 1:50 in
fresh SD-ura and grown to midlogarithmic phase (OD600
0.6-0.8). The cultures were harvested (1.5 ml) by centrifu-
gation for 1 min in an Eppendorf centrifuge. After suspension
of the cell pellets in 150 Al ofZ buffer (13), 50 Al of chloroform
and 20 ,l of 0.1% SDS were added. The mixture was mixed
vigorously for 30 sec to permeabilize the yeast cell walls. To
Abbreviations: MCB, Mlu I cell cycle box; SCB, SWI4,6-dependent
cell cycle box; UAS, upstream activation sequence.
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initiate the /B-galactosidase reaction, 700 dul of a 1.2-mg/ml
solution of o-nitrophenyl f-D-galactopyranoside (Sigma) was
added to each cell suspension. Reaction mixtures were
incubated at 300C until a faint yellow color was visible, at
which time the reaction was quenched by addition of 500 ILI
of 1 M sodium carbonate. The cell debris was pelleted and the
OD420 of the supernatant was recorded. The 3-galactosidase
activity in each reaction was calculated as Miller units (13),
(OD420 X 1000)/[OD600 x volume of cells (ml) x time (min)].
Detergent Method of Eatract Preparation. Yeast cells were
grown at 30'C to an OD600 of 0.2-0.5 in YPD medium unless
otherwise indicated. Cells were harvested by centrifugation
in a GSA rotor (Sorvall) at 5000 rpm for 5 min at 40C and the
pellet was washed with ice-cold water. All subsequent steps
were performed on ice. The pellet was suspended in 2
volumes of lysis buffer containing 50 mM Tris (pH 7.5) 0.2%
Nonidet P-40, 0.3 M KCl, 10%o (vol/vol) glycerol, 5 mM
EDTA, leupeptin, chymostatin, and antipain at 10 pug/ml,
pepstatin at S ,ug/ml, 5 mM dithiothreitol, 0.5 mM phenyl-
methanesulfonyl fluoride, and 0.5 mM benzamidine. Ice-
cold, acid-washed and baked glass beads were added, and the
cells were lysed by mixing each tube for 4 x 30 sec with
intermittent cooling. The lysate was then spun at 20,000 rpm
for 20 min in a 50 Ti rotor (Beckman). The clear supernatant
was frozen in a dry ice/ethanol mixture and stored at either
-70°C or in liquid nitrogen.
High-Salt Method of Yeast Extract Preparation. Exponen-
tially growing yeast cells were harvested as above and then
resuspended in lysis buffer containing 20mM Hepes (pH 8.0),
1 mM EDTA, 10%o glycerol, 5 mM dithiothreitol, 1.0 M KCl,
and the protease inhibitors described above. Cells were lysed
using glass beads and the cell debris was pelleted by spinning
in a microcentrifuge for 5 min. The cleared supernatant was
then dialyzed against the lysis buffer, except that the salt
concentration was reduced to 50 mM KCl.
Mobility-Shift Assay. A 45-base-pair (bp) oligonucleotide
containing three Mlu I sites in tandem was 5' end-labeled
using T4 kinase and used as a binding probe throughout. The
sequence of the top strand was 5'-TCGACTCAAACGCGT-
TCGACAACGCGTTCGACAACGCGTTCGAGA-3'. The
binding reaction mixture typically contained 20 ,ug ofprotein,
50 mM Tris (pH 7.5), 15% glycerol, 25 mM MgCl2, and
poly(dIdC) at 0.25 ,ug/ml and was incubated on ice for 10
min. Reaction products were resolved in a 4% polyacryl-
amide gel in 44.5 mM Tris/44.5 mM boric acid/1.0 mM
EDTA. The gels were dried and autoradiographed at -70°C
with intensifying screens.
Northern Blot Analysis. RNA was prepared from logarith-
mic-phase cultures and blotted essentially as described by
Gordon and Fantes (14). Each sample contained 30 Ag of
RNA. The probes were pPOL1-4 (15) and the EcoRI-HindlI
fragment of the actin gene (5). They were labeled with a
random primed DNA labeling kit (Boehringer Mannheim).
RESULTS
MCB-Driven UAS Activity Is Dependent on SWI6. To test
whether SWI4 or SWI6 might act at the MCB sequences to
activate transcription, we made use of the ability of synthetic
MCB elements to activate transcription of a test gene (4-6).
We have constructed plasmids similar to those of McIntosh
et al. (4) and Lowndes et al. (6) in which two (pBA489), three
(pBA486), or four (pBA487) copies of the MCB sequence are
tandemly arranged upstream of a CYC-lacZ fusion gene
lacking its own UAS. These constructs were transformed into
wild-type cells and swi4A or swi6A& mutant cells. MCB-
mediated transcription was assayed by measuring f3-galacto-
sidase activity in the yeast transformants (Table 1). TheMCB
sequence was able to function efficiently as an UAS in
wild-type and swi4A strains but was completely unable to
Table 1. The MCB sequence acts as an SWI6-dependent UAS
P-Galactosidase units
J014 J022 J023
Plasmid (wild-type) (swi4A) (swi6A)
pBA489 (two MCBs) 16.1 1.95 0.45
pBA486 (three MCBs) 43.5 7.75 0.42
pBA487 (four MCBs) 118 60.2 0.25
pBA249 (two HO SCBs) 22.5 0.842 0.52
pBA67 (ribosomal protein
39 UAS) 838 838 820
pASS vector 0.26 0.13 0.14
Wild-type, swi4A, and swi6A cells were transformed with
MCB::IacZ plasmids (pBA489, 486, and -487) carrying two, three,
or four copies of a synthetic MCB sequence inserted upstream of a
CYC::IacZ fusion gene. P-Galactosidase activity of the plasmids is
dependent on the inserted MCB sequences. Results are the average
of three to four assays using independent yeast transformants. The
(3-galactosidase activity of a nonspecific UAS (pBA67) is reduced
somewhat in swi4A and swi6M mutant strains due to their compro-
mised growth. All numbers were normalized to the activity ofpBA67
in the wild-type strain. Both plasmid pBA67 and plasmid pBA249
have been described (7, 16). pBA249 contains two copies of the SCB
sequence and serves as a SWI4- and SWI6-dependent control. Strains
JO14, J022, and J023 have been described (8).
function in the swi6A mutant strain. Although reductions in
the UAS activity of the MCB sequence were found in the
swi4A strain (2- to 8-fold), the requirement for SWI6 in
activating transcription through the MCB was absolute.
These results contrast with studies of the SCB sequence
(pBA249; Table 1), which is completely dependent on both
SWI4 and SWI6 in order to function as an activating sequence
in an identical assay (7, 16). We interpret the large difference
in the requirement for SWI4 and SWI6 for the activation of
transcription from the MCB sequences as indicating a spe-
cific requirement for SWI6 in this process.
DNA-Protein Complexes Formed on the MCB in Vitro with
Detergent or High-Salt Lysate. To investigate the molecular
basis of the in vivo results presented above, we developed a
biochemical assay for the formation of specific DNA-protein
complexes on the MCB. Exponentially growing cells were
harvested and disrupted in the presence of detergent (Fig.
1A) or high salt (Fig. 1B). Mobility-shift assays performed
with a labeled probe containing three tandem MCB elements
revealed several DNA-protein complexes. The slowest mov-
ing complex, complex 1, was observed only in extracts
prepared with detergent (Fig. 1A). Complex 1 was judged to
be MCB-specific, since its formation was blocked by a
15-fold excess of self sequence or the CDC6 promoter-
derived oligonucleotide C6. (Oligonucleotide C6 contains one
Mlu I site and a near match in close proximity.) Unrelated
oligonucleotides containing the binding site for the yeast heat
shock transcription factor, as well as mutant self-sequence,
failed to compete for complex formation even when present
in the reaction mixture at a 30-fold molar excess relative to
the labeled probe. Complex 2 was observed in extracts
prepared by either method. Complex 2 was alsojudged to be
MCB-specific on the basis of competition assays. There was
complete competition by a 30-fold excess of self or C6
oligonucleotides in the high-salt extracts (Fig. 1B) and partial
competition by the same oligonucleotides in detergent ex-
tracts. A third major complex (complex 3 in Fig. 1) wasjudged to be nonspecific, since nonradioactive MCB oligo-
nucleotide failed to abolish its formation.
Complexes of higher mobility than complexes 1-3 were
C6-specific but the trimeric tandem MCB sequence was a
poor competitor. It is possible that these complexes recog-
nize MCB in the monomeric form, because their formation
was also blocked by an oligonucleotide derived from the
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FIG. 1. Binding specificity of complexes formed on the trimeric
MCB (ACGCGT)-containing DNA probe. (A) Mobility-shift assays
were performed with 20 ,ug of yeast extract, prepared by the
detergent method, in the presence of poly(dIdC) or various com-
petitors present at either 15- or 30-fold in excess over labeled probe.
C6 oligonucleotide is derived from the CDC6 promoter and contains
one Mlu I site and one near match [... GACGCGAGGCCT-
CACGCGT ... (18, 19)]. The mutant oligonucleotide has each ofthe
three Mlu I sites mutated to ACtaGT. The HSE oligonucleotide
contains the heat shock recognition element for the heat shock
transcription factor (20). (B) Binding conditions and competitors
were as described for A except that the yeast extract was prepared
by the high-salt method.
POLI oligonucleotide, which contained two Mlu I sites
spaced 19 bp apart (data not shown).
Lack of Complex 1 Formation in swi6A, but Not swi4A,
Mutant Cells. Both SWI4 and SWI6 are known to function as
components of a protein complex that binds to the SCB
sequences upstream of the HO and cyclin genes. To examine
the possibility that the requirement for SWI6, and to a lesser
degree, SWI4, for the UAS activity ofthe MCB sequence (as
demonstrated in Table 1) was due to the participation ofSwi6
and Swi4 in protein complex formation at the MCB sequence,
we prepared extracts from isogenic wild-type, swi4A, and
swi6A strains. The results shown in Fig. 2A were obtained
using extracts prepared by the detergent method, conditions
optimal for visualization ofcomplex 1. Complex 1 was absent
from swi6A extract but was present in swi4A extract. Thus,
complex 1 formation shows the same genetic requirements as
UAS activity of the MCB sequence in vivo.
Complex 2 formation was also sensitive to SWI6, since
levels were reduced in swi6A mutants relative to the wild type
when extracts were prepared by the high-salt method (Fig.
2B). The decrease in complex 2 was specific to the absence
of the SWI6 gene product: transformation of a swi6A deletion
mutant by the wild-type SWI6 gene restored binding activity
to wild-type levels (Fig. 2B). Although complex 2 did not
appear to be affected in a swi4A mutant, in that levels were
comparable to wild type (data not shown), an effect of
deleting swi4 was unmasked in a swi4Aswi6A double mutant
(Fig. 2C). The effect of the swi4 deletion on complex 2
formation in extracts from the double mutant was greater in
extracts prepared by the high-salt method than in detergent
extracts (compare Fig. 2 A and C). It may be that preparation
of extracts in high salt renders Swi6 protein (and whatever
else is involved) much less stable.
Complex 1 Formation Is Induced and Complex 2 Formation
Is Abolished Following a-Factor Arrest. A binding activity,
FIG. 2. Requirement for the SWJ6 gene product forMlu I-specific
binding activity. Exponential populations ofwild-type cells (WT) and
swi4A, swi6A, swi6A/pSWI6, and swi4Aswi6A/pCLN2 mutant
strains growing at 30°C were harvested, and yeast extract was
prepared by the detergent (A) or the high-salt (B and C) method.
Mobility-shift assays were carried out using 20 ,ug of extract protein.
termed DSC1, that specifically recognizes the MCB sequence
was previously identified (6). DSC1 activity was found to
increase during incubation of cells with a-factor, a phero-
mone that arrests cells in G1. An MCB-driven reporter gene
was found to exhibit a similar increase in activity when cells
were arrested with a-factor. This behavior stands in contrast
to the transcription ofgenes driven by theMCB in the context
of the native promoter: transcription of genes such as POLI,
RNRI, and CDC9 decreases during cell cycle arrest with
a-factor and requires new protein synthesis to resume (21,
22). To investigate whether complexes 1 and 2 corresponded
to DSC1 or exhibited new properties, we prepared extracts
from cells growing exponentially (Fig. 3, lane 2) or arrested
with a-factor for 2 hr (lane 1) or 4 hr (lane 3). Complex 1
formation was increased by incubation in the presence of
a-factor. The competition binding data and the effect of
a-factor thus suggest that complex 1 might contain DSC1.
DSC1 binding has been reported to be periodic following an




FIG. 3. Analysis of Mlu I-specific
binding activity in cells arrested in G1
with a-factor. An aliquot of bar] cells
(for strain description see ref. 5; the
bar)-) mutation reduces degradation
of a-factor) growing exponentially at
30°C was harvested (lane 2) while
another aliquot was arrested with
a-factor (300 ng/ml) for 2 hr (lane 1) or
4 hr (lane 3) before harvest. Yeast
extracts were prepared from each cul-
ture by the detergent method and mo-
bility-shift assays were performed.
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In contrast to complex 1, complex 2 formation was de-
creased after 2 hr in the presence of a-factor and was
drastically reduced following incubation with a-factor for 4 hr
(Fig. 3, lane 3). That this reduction in complex 2 levels was
not due to general proteolysis is evidenced from the obser-
vation that complex 1 levels remained reproducibly high
following incubation with a-factor for two cell cycles (4 hr,
lane 3). Thus, complex 2 seems to be distinct from DSC1, and
complex 2 levels parallel the transcription pattern oftheDNA
replication genes in their native context.
Protein Synthesis Is Required for Complex 2 Formation
Following Release From an a-Factor Block. As described
above, de novo protein synthesis is required for the induction
ofDNA replication genes following arrest in G1 with a-factor
(21, 22). As demonstrated by Marini and Reed (22), the
requirement reflects specific resynthesis of a subset of G1
cyclins that are degraded following a-factor treatment, re-
sulting in a block in cell cycle progression. Since complex 2
levels were drastically reduced in a-factor-arrested cells (Fig.
3, lane 3), we sought to determine the effect of cyclohexi-
mide, a protein synthesis inhibitor, on complex 2 formation.
Complex 2 binding activity in high-salt extracts was com-
pared for a-factor-arrested cells and cells that were released
from G1 arrest by washing out the a-factor in the presence or
absence of cycloheximide. Complex 2 was completely absent
from a-factor-arrested cells (Fig. 4, lane 2). Complex 2
reappeared within 2 hr after release from G1 arrest in the
absence of cycloheximide (lane 5) but was completely
blocked in the presence of cycloheximide (lane 4). Thus,
complex 2 exhibits two properties consistent with the behav-
ior of MCB-driven genes in their native configuration: (i)
sensitivity to arrest by pheromone and (ii) a requirement for
new protein synthesis for the reestablishment of complex
formation following pheromone arrest.
Steady-State POLI Transcript Levels in swi4A and swi6A
Mutant Cells. Using POLl::lacZ constructs, Gordon and
Campbell (5) showed that when both Mlu I sites were
eliminated from a synthetic POLl promoter, lacZ expression
was greatly reduced in asynchronous cultures. Periodicity
was also completely lost (5). Similar results were obtained
with the TMPI gene. TMPI, which has two Mlu I (ACGCGT)
sites spaced 30 bp apart, preferentially utilizes the 5' distal
site to drive periodic transcription (4). Site-directed muta-
genesis resulting in a single G -- T transversion in the 5' site





FIG. 4. New protein synthe-
sis is required for formation of
complex 2. An exponential pop-
ulation of bar] cells growing at
30TC (lane 1) was arrested with
a-factor (300 ng/ml) for 4.5 hr
(lanes 2 and 3). An aliquot of the
arrested culture was filtered,
washed, and resuspended in
fresh YPD medium containing
either cycloheximide (50 Ag/ml)
(lane 4) or no cycloheximide
(lane 5). Released cultures were
harvested after 2 hr. At this
time, the cell number of cultures
with no cycloheximide had dou-
bled and budding population
was >50%o. Extracts from eachof the above cultures were pre-
pared by the high-salt method
and used for mobility-shift as-
2 3 4 5 says.
of TMPI transcript in asynchronous cultures. Thus, as was
the case for POLI, periodicity, as well as activation, seems
to be regulated through the same Mlu I-site-containing se-
quence element. Since the SWI6 effect, and to a lesser extent
the SWI4 effect, is also mediated through the Mlu I element
(Table 1), we wished to determine whether steady-state
POLI transcript levels were reduced in swi4A and swi6A
mutants.
Northern blot analysis showed no difference in POLl
transcript levels among wild-type, swiA, and swi6A cells
(Fig. 5). Since the results of the RNA analysis were unex-
pected, we determined POLI promoter activity by an alter-
native method. B-Galactosidase activity was determined in
wild-type, swi4A, and swi6A strains carrying a plasmid con-
taining the full-length POLI promoter fused to the lacZ
reporter gene (5). Consistent with the RNA analysis, no
difference in activity was seen in the mutants compared with
the wild type (data not shown). Although these experiments
did not test the effect ofthe absence ofSWI4 and SWI6 on the
periodicity ofPOLI transcription, we can conclude that the
SWI4 and SWI6 products are not required for activation of
POLI transcription through the MCB.
DISCUSSION
The results define another role for the well-studied transcrip-
tional activator encoded by the yeast SWI6 gene. Although
the MCB motif (ACGCGT) conferring periodicity on the
DNA replication genes is different from the originally defined
consensus site of Swi4/Swi6 protein interaction (7, 10), we
have found that MCB-dependent UAS activity is completely
dependent on SWI6. Consistent with the in vivo data, we
observed two MCB-specific complexes in vitro that were
either abolished (complex 1) or significantly reduced (com-
plex 2, Fig. 2) in a swi6A mutant.
Complex 1 formation represents a biochemical correlate of
the in vivo data in that complex 1 is formed when extracts are
prepared from swi4A mutants but not from swi6A mutants.
These observations indicate that SWI6 can act independently
of SWI4 to promote binding to DNA and transcriptional
activation. In its previously recognized role in activating
transcription through the SCB sequences upstream of HO
and certain cyclin genes, SWI6 functions together with SWI4
(7-9).
Previous studies of cell cycle-specific expression of the
DNA replication genes have documented the absence of
expression of these genes in a-factor-arrested cells. Reentry
into the cell cycle following a-factor removal is accompanied
POL 1-I -
ACT -> _I
FIG. 5. Northern analysis ofPOLl message in wild-type, swi4,
and swi6A strains. Total RNA was prepared and blotted. The blot
was probed for both POLI and actin (ACT) transcripts. Message
sizes were determined by comparison with 18S and 255 rRNA. A
shorter exposure (not shown) was used to normalize for POLI levels
against actin transcript levels, and no significant difference was
found among the three strains.
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by an increase in expression that requires a fresh round of
protein synthesis (21, 22). Mirroring this observation, we
have found that binding activity contributing to complex 2 is
absent from a-factor-arrested cells and is not restored fol-
lowing removal of the cell cycle block in the presence of
cycloheximide (Fig. 4). By contrast, complex 1 is increased
in a-factor-arrested cells. Thus, complex 2 may more closely
reflect DNA-protein interactions important in vivo following
G1 arrest. Further evidence for the physiological significance
of complex 2 is our observation that complex 2, while absent
from cells arrested at the start of the cell cycle by a-factor
(Fig. 4), is present in cdc28fs arrested cells (data not shown).
Marini and Reed (22) have shown that protein synthesis is not
required for induction of transcription of CDC9 after release
from a cdc28ts block in G1. These data suggest that the
DNA-binding proteins must already be present during a
cdc28 arrest and that activation following release may require
posttranslational modification by Cdc28 protein kinase.
Our results indicate an important difference between the
group of genes known to be directly regulated by SWI6
(SCB-driven genes such as HO, CLN2, and HCS26) and the
DNA replication genes. In the former case, the steady-state
levels of HO, CLNJ, and CLN2 transcripts are reduced in a
swi6A mutant, ranging from a modest effect on CLN2 to a
larger effect on HO (9, 17). In the case ofthe DNA replication
genes, our data indicate an absolute dependence on SWI6 for
transcriptional activation through isolated MCB sequences
and a requirement for SWI6 in the optimal formation of
protein complexes at this sequence. However, we see no
effect ofa swi6A deletion mutant on the steady-state levels of
POLI transcripts. That is, SWI6 is not required for activation
of transcription through the MCB sequences upstream of
POLL. This result was somewhat surprising, given our in vivo
and in vitro evidence establishing a role for SWI6 in activating
transcription through the MCB. As stated earlier, previous
work has demonstrated a requirement for the MCB, both for
efficient UAS activity and for periodicity for the POLI
promoter (5). In addition, McIntosh et al. (4) observed that
steady-state levels of TMPI transcripts were drastically,
reduced by mutations in the MCB, suggesting a central role
for this sequence in driving transcription of TMPL. If Swi6
were the key factor binding to the MCB sequence and
activating transcription, we would have expected to see a
reduction in POLI transcription in the swi6A mutant. Since
this is clearly not the case, and yet a role for the MCB
sequences in the POLI UAS in periodic expression has been
firmly established (5), we suggest that another protein (or
proteins) is binding to the MCB and activating transcription.
SWI6 may serve to regulate the formation and activity of the
above complex, perhaps thus providing a link to cell cycle
position. A candidate for a direct MCB-binding factor,
MCBF, has been purified from yeast extracts (18). It remains
to be seen whether MCBF and Swi6 interact. In addition, we
expect that periodic transcription of POLI is deregulated in
swi6A mutants, since our data demonstrate a role for SWI6 in
MCB activity (Table 1).
The Swi6 protein bears functional and structural similarity
to the cdc10 protein from the fission yeast Schizosaccharo-
myces pombe (24). Of particular relevance to this discussion
is the recent finding that cdc10 is a component of a transcrip-
tion factor that forms on the MCB sequences of the cdc22+
gene of Sch. pombe (23). Like SWI4 and SWI6, the cdc10O
gene is known to be involved in key events at the beginning
of the mitotic cell cycle since mutants in cdclO arrest at start.
Given the recent findings demonstrating a role for cdclO in
recognizing the MCB sequences, it seems likely that one of
the essential functions of cdclO+ for passing the cell cycle
start is to induce transcription of DNA synthesis genes. The
similarity between the protein sequences of cdclO and Swi6,
as well as results presented here demonstrating a role for
SWI6 in the function of MCB sequences in budding yeast,
suggests that SWJ6 and cdclO+ may represent functional
homologues from distantly related yeasts. It seems likely that
homologues of SWI6 remain to be discovered in other eu-
karyotes.
Note Added in Proof. Since this manuscript was submitted, two
papers (25, 26) have been published demonstrating the presence of
Swi6 in complexes formed on the MCB. Aberrant regulation of the
DNA replication gene family was observed in a swi6A mutant.
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